Swiss Amyloidosis Network (SAN): Objectives and Challenges
Systemic amyloidoses are chronic diseases with important consequences for patients' quality of life, thus presenting a major medical and socioeconomic burden. This article discusses the current diagnostic challenges and therapy options for systemic amyloidosis and summarizes the activities of t...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
THE HEALTHBOOK COMPANY LTD.
2023-12-01
|
| Series: | healthbook TIMES. Oncology Hematology |
| Online Access: | https://doi.org/10.36000/HBT.OH.2023.18.129 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850257142568714240 |
|---|---|
| author | Rahel Schwotzer Bernhard Gerber Andreas Flammer Axel Rüfer |
| author_facet | Rahel Schwotzer Bernhard Gerber Andreas Flammer Axel Rüfer |
| author_sort | Rahel Schwotzer |
| collection | DOAJ |
| description | Systemic amyloidoses are chronic diseases with important consequences for patients' quality of life, thus presenting a major medical and socioeconomic burden. This article discusses the current diagnostic challenges and therapy options for systemic amyloidosis and summarizes the activities of the Swiss Amyloidosis Network (SAN) which aims to increase awareness of these rare diseases, include patients in the Swiss Amyloidosis Registry for research purposes and develop interdisciplinary guidelines for diagnosis and therapy of systemic amyloidosis in Switzerland.
PEER REVIEWED ARTICLE
Peer reviewers:
Prof. Dr Ute Hegenbart (University Hospital Heidelberg, Heidelberg, Germany);
One anonymous peer reviewer.
Submitted: November 30, 2023 CEST; Accepted: December 03, 2023 CEST |
| format | Article |
| id | doaj-art-231adcd62a1c4295addecd9cd992d7e8 |
| institution | OA Journals |
| issn | 2673-2092 2673-2106 |
| language | English |
| publishDate | 2023-12-01 |
| publisher | THE HEALTHBOOK COMPANY LTD. |
| record_format | Article |
| series | healthbook TIMES. Oncology Hematology |
| spelling | doaj-art-231adcd62a1c4295addecd9cd992d7e82025-08-20T01:56:29ZengTHE HEALTHBOOK COMPANY LTD.healthbook TIMES. Oncology Hematology2673-20922673-21062023-12-0118410.36000/HBT.OH.2023.18.129Swiss Amyloidosis Network (SAN): Objectives and ChallengesRahel SchwotzerBernhard GerberAndreas FlammerAxel RüferSystemic amyloidoses are chronic diseases with important consequences for patients' quality of life, thus presenting a major medical and socioeconomic burden. This article discusses the current diagnostic challenges and therapy options for systemic amyloidosis and summarizes the activities of the Swiss Amyloidosis Network (SAN) which aims to increase awareness of these rare diseases, include patients in the Swiss Amyloidosis Registry for research purposes and develop interdisciplinary guidelines for diagnosis and therapy of systemic amyloidosis in Switzerland. PEER REVIEWED ARTICLE Peer reviewers: Prof. Dr Ute Hegenbart (University Hospital Heidelberg, Heidelberg, Germany); One anonymous peer reviewer. Submitted: November 30, 2023 CEST; Accepted: December 03, 2023 CESThttps://doi.org/10.36000/HBT.OH.2023.18.129 |
| spellingShingle | Rahel Schwotzer Bernhard Gerber Andreas Flammer Axel Rüfer Swiss Amyloidosis Network (SAN): Objectives and Challenges healthbook TIMES. Oncology Hematology |
| title | Swiss Amyloidosis Network (SAN): Objectives and Challenges |
| title_full | Swiss Amyloidosis Network (SAN): Objectives and Challenges |
| title_fullStr | Swiss Amyloidosis Network (SAN): Objectives and Challenges |
| title_full_unstemmed | Swiss Amyloidosis Network (SAN): Objectives and Challenges |
| title_short | Swiss Amyloidosis Network (SAN): Objectives and Challenges |
| title_sort | swiss amyloidosis network san objectives and challenges |
| url | https://doi.org/10.36000/HBT.OH.2023.18.129 |
| work_keys_str_mv | AT rahelschwotzer swissamyloidosisnetworksanobjectivesandchallenges AT bernhardgerber swissamyloidosisnetworksanobjectivesandchallenges AT andreasflammer swissamyloidosisnetworksanobjectivesandchallenges AT axelrufer swissamyloidosisnetworksanobjectivesandchallenges |